Navigation Links
MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
Date:3/10/2008

NEW YORK and LONDON, March 10 /PRNewswire/ -- Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on meeting the challenges of measuring ROI within the changing dynamics of the pharma industry.

*(LOGO 72dpi: Send2Press.com/mediaboom/07-0924-Eularis_72dpi.jpg)

On Wednesday 26 March 2008, Dr. Bates will deliver a presentation titled, "Are You Up to the Challenge of Measuring ROI in Changing Dynamics of the Pharma Industry?" Bates will challenge the thinking of conference attendees and will expose where ROI goes wrong when used to guide current marketing decisions in a changing dynamic market such as pharma. She will also uncover what opportunities are available in this environment, and what can and should be measured for real results when the environment is dynamic.

Bates has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis. Under Bates' leadership, Eularis issued three related research reports in the past year, including: Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line (http://www.pharmamarketingroi.com), Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things? (http://www.pharmaindustrysfe.com), and Ensuring Profitable Patient Adherence Programs by Effectively Using Analytics to Release the Hidden Value Available to the Bottom Line from Adherence (http://www.patientadherenceroi.com).

The conference will be focused on answering three pivotal areas: "Addressing the Challenges in Measuring ROI," "Ensuring the Sales and Marketing Functions are Aligned" and "Leveraging Your Brand Potential."

To arrange an interview with Eularis http://www.eularis.com, please contact Tracey Haefele at +1 646 673 8408 or via email THaefele@Eularis.com.

About Eularis

Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance. Eularis offers pre-launch analytics, marketing mix modeling, portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Eularis has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others.

For more information about Eularis, visit http://www.eularis.com.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE Eularis
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Grey House Publishing Acquires Hudsons Washington News Media Contacts Directory
2. NAA Calls for Immediate Recall of All Mercury-Containing Vaccines
3. VIDEO from Medialink and General Motors: Electronic Prescriptions Save Lives and Money
4. HealthMedia Fourth Quarter 2007 Produces Highest Revenue in Company History
5. VIDEO from Medialink and The Childrens Hospital of Philadelphia: New Research - Rules of the Road for Teens and Passengers
6. Media Invited to Attend International Society for Heart & Lung Transplantation Meeting in Boston, April 9-12
7. VIDEO from Medialink and Philips: Philips Electronics Unveils First Imagination Light Canvas at the New Mercy Medical Center in Rogers AR
8. VIDEO from Medialink and Shire plc: Rare Diseases Must Be Top of the Health Agenda
9. Webcast Alert: Medial Saude S/A Announces Fourth Quarter 2007 Earnings Conference Call Webcast
10. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
11. AUDIO from Medialink and Kelloggs: A Healthy Beginning Every Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... 24, 2017 , ... Medic CE , a Career Step company, is ... Shock” hosted by the Journal of Emergency Medical Services (JEMS). The free webinar, to ... presented by Captain Rommie Duckworth, LP, a career fire captain as well as founder ...
(Date:5/24/2017)... ... May 24, 2017 , ... Rob Lowe is a sought after actor, and ... “Informed” brings the public important topics from all aspects of life, and a new ... issues surrounding feet and ankles. , Podiatry is essential to people’s overall well-being, and ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... based sleep diagnostics sensors, announced today it had completed the first phase of ... mix of domestic and rest of world (ROW) authorized dealers specializing in polysomnography ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... the pharmaceutical and medical device sectors, today announced the winners of its 3rd ... Entrepreneurs) represent the most influential people in the healthcare industry today. , Out ...
(Date:5/23/2017)... ... ... The National Council on Strength and Fitness (NCSF), a ... Strength Coach credential has earned accreditation from the National Commission for Certifying Agencies ... qualified candidates for jobs in the Strength and Conditioning profession. The CSC distinction ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)... PLEASANTON, Calif. , May 23, 2017 /PRNewswire/ ... world,s most innovative medical devices for pressure ulcer ... at the American Association of Critical Care Nurses, ... Houston May 22-25. The Leaf Patient ... designed specifically for the hospital environment.  The system ...
(Date:5/22/2017)... MAITLAND, Fla. , May 22, 2017 /PRNewswire/ ... industry as a whole continue to make the ... evidence becomes increasingly important for ensuring positive patient ... Key industry stakeholders are shifting focus away from ... results and effects of long-term specialty drug therapy ...
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
Breaking Medicine Technology: